‘Don’t get suckered like I did’: I paid $185 to the wrong passport website. Can I get my money back?
“I will file a complaint with the Better Business Bureau.”
Similar Posts
Can Manipal Health IPO deliver long-term growth for high risk investors?
ET Intelligence Group: Manipal Health Enterprises, a healthcare service provider, plans to raise ₹8,000 crore through a fresh issue for repayment of debt, acquisition of stake in the subsidiary and general corporate purposes. It will also raise ₹1,275 crore through an offer for sale. The promoter group’s stake will fall to 72.1% after the IPO…
One Late Payment Can Stay on Your Credit Report for Seven Years
Advertiser Disclosure The credit card and banking offers that appear on this site are from credit card companies and banks from which MoneyCrashers.com receives compensation when a customer clicks on a link, when an application is approved, or when an account is opened. This compensation may impact how and where products appear on this site,…
Delhi Traffic Advisory: Diversions, Key Routes To Avoid From July 20 Ahead of Parliament Monsoon Session
News Published: Sunday, July 19, 2026, 20:20 [IST] Delhi Traffic Advisory: The coming week can be chaotic for daily commuters, especially motorists in Delhi due to diversions and special traffic arrangements ahead of the Monsoon Session of Parliament. The session will begin on Monday, July 20, 2026. The monsoon session’s first day will coincide with…
Top Biotech Gainers: ZYBT Skyrockets, ADVB Drops Planned Offering, STIM Gets New CFO, RDGT On Watch
(RTTNews) – Today’s top biotech gainers include Zhengye Biotechnology, a veterinary vaccine manufacturer, which surged, easing Nasdaq delisting concerns; Advanced Biomed, which gained after withdrawing its planned U.S. securities offering and reducing potential dilution concerns; Neuronetics, following the appointment of a new CFO; and Armata Pharmaceuticals, which advanced its Phase 3 pathway for lead bacteriophage…
Cathie Wood Bought $53.5 Million of Tesla Stock Right After Elon Musk’s Post-Earnings Sell-Off. Is a Rebound Coming?
Tesla‘s (TSLA -2.97%) second-quarter update failed to impress the market. The company’s core electric vehicle (EV) business performed well, with deliveries growing by a strong 25% year over year to 480,126, well ahead of the consensus analyst estimate. This helped power healthy top-line growth. The company’s revenue climbed by 26% year over year to $28.2…
Don’t Wait for the IPO — Find the Next AI Winner Now
The biggest AI fortunes may be made before a company ever goes public. Listen to the audio version of this article (generated by AI). Editor’s Note: Most people think the biggest fortunes in technology are made after a company goes public. My InvestorPlace colleague Luke Lango believes that assumption is becoming increasingly outdated. In today’s…
